关注
Yingtian Xie
Yingtian Xie
Dana Farber Cancer Institute
在 dfci.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway
KJ Kurppa, Y Liu, C To, T Zhang, M Fan, A Vajdi, EH Knelson, Y Xie, ...
Cancer cell 37 (1), 104-122. e12, 2020
3372020
Integrative analyses of single-cell transcriptome and regulome using MAESTRO
C Wang, D Sun, X Huang, C Wan, Z Li, Y Han, Q Qin, J Fan, X Qiu, Y Xie, ...
Genome biology 21, 1-28, 2020
1342020
Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade
SS Gu, W Zhang, X Wang, P Jiang, N Traugh, Z Li, C Meyer, B Stewig, ...
Cancer discovery 11 (6), 1524-1541, 2021
1222021
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
X Qiu, N Boufaied, T Hallal, A Feit, A de Polo, AM Luoma, W Alahmadi, ...
Nature communications 13 (1), 2559, 2022
802022
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
P Cejas, Y Xie, A Font-Tello, K Lim, S Syamala, X Qiu, AK Tewari, N Shah, ...
Nature communications 12 (1), 5775, 2021
802021
Juvenile hormone activates the transcription of cell-division-cycle 6 (Cdc6) for polyploidy-dependent insect vitellogenesis and oogenesis
Z Wu, W Guo, Y Xie, S Zhou
Journal of Biological Chemistry 291 (10), 5418-5427, 2016
692016
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence
Z Wu, J Zhou, X Zhang, Z Zhang, Y Xie, J Liu, ZV Ho, A Panda, X Qiu, ...
Nature genetics 53 (6), 881-894, 2021
542021
Hsa_circ_0001859 regulates ATF2 expression by functioning as an miR‐204/211 sponge in human rheumatoid arthritis
B Li, N Li, L Zhang, K Li, Y Xie, M Xue, Z Zheng
Journal of immunology research 2018 (1), 9412387, 2018
542018
Chromatin accessibility promotes hematopoietic and leukemia stem cell activity
L Cabal-Hierro, P van Galen, MA Prado, KJ Higby, K Togami, CT Mowery, ...
Nature communications 11 (1), 1406, 2020
512020
TRPS1 is a lineage-specific transcriptional dependency in breast cancer
RM Witwicki, MB Ekram, X Qiu, M Janiszewska, S Shu, M Kwon, A Trinh, ...
Cell reports 25 (5), 1255-1267. e5, 2018
502018
Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells
RE Tay, O Olawoyin, P Cejas, Y Xie, CA Meyer, Y Ito, QY Weng, ...
Journal of Experimental Medicine 217 (7), e20191453, 2020
442020
An enhancer-driven stem cell–like program mediated by SOX9 blocks intestinal differentiation in colorectal cancer
X Liang, GN Duronio, Y Yang, P Bala, P Hebbar, S Spisak, P Sahgal, ...
Gastroenterology 162 (1), 209-222, 2022
382022
Androgen receptor is a non-canonical inhibitor of wild-type and mutant estrogen receptors in hormone receptor-positive breast cancers
S Ponnusamy, S Asemota, LS Schwartzberg, F Guestini, KM McNamara, ...
Iscience 21, 341-358, 2019
292019
CoBRA: containerized bioinformatics workflow for reproducible ChIP/ATAC-seq analysis
X Qiu, AS Feit, A Feiglin, Y Xie, N Kesten, L Taing, J Perkins, S Gu, Y Li, ...
Genomics, Proteomics and Bioinformatics 19 (4), 652-661, 2021
262021
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes
EJ Schaefer, HC Wang, HQ Karp, CA Meyer, P Cejas, MD Gearhart, ...
Blood cancer discovery 3 (2), 116-135, 2022
242022
FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissues
A Font-Tello, N Kesten, Y Xie, L Taing, D Varešlija, LS Young, AA Hamid, ...
Nature Protocols, 1-16, 2020
232020
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance
Y Li, X Qiu, X Wang, H Liu, RC Geck, AK Tewari, T Xiao, A Font-Tello, ...
Nature cell biology 23 (11), 1187-1198, 2021
222021
Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma
J Zhou, Z Wu, Z Zhang, L Goss, J McFarland, A Nagaraja, Y Xie, S Gu, ...
Gut 71 (4), 665-675, 2022
172022
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
L Duplaquet, Y Li, MA Booker, Y Xie, SN Olsen, RA Patel, D Hong, ...
Nature Cell Biology 25 (9), 1346-1358, 2023
162023
YAP1 and PRDM14 converge to promote cell survival and tumorigenesis
M Kim, SH Ly, Y Xie, GN Duronio, D Ford-Roshon, JH Hwang, R Sulahian, ...
Developmental cell 57 (2), 212-227. e8, 2022
162022
系统目前无法执行此操作,请稍后再试。
文章 1–20